The privilege and responsibility of having choices: Decision-making for new vaccines in developing countries

Health Policy and Planning

Volumn 27, Issue SUPPL.2, 2012, Pages

  Mantel, Carsten ^a   Wang, Susan A ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Decision making; immunization; vaccines

Indexed keywords

VACCINE;

DEVELOPING COUNTRY; EDITORIAL; HUMAN; MANAGEMENT; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; SOCIAL BEHAVIOR;

DECISION MAKING, ORGANIZATIONAL; DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; POLICY MAKING; SOCIAL RESPONSIBILITY; VACCINES;

EID: 84860156034     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czs041     Document Type: Review

References (26)

1. Brooks A, Ba-Nguz A. 2012. Country planning for health interventions under development: lessons from the malaria vaccine decisionmaking framework and implications for other new interventions. Health Policy and Planning 27(Suppl. 2):ii50-ii61.
2. Bryson M, Duclos P, Jolly A, Cakmak N. 2010. A global look at national immunization technical advisory groups. Vaccine 28(Suppl. 1):A13-17.
3. Burchett HED, Mounier-Jack S, Griffiths UK et al. 2012. New vaccine adoption: qualitative study of nation decision-making processes in seven low- and middle-income countries. Health Policy and Planning 27(Suppl. 2):ii5-ii16.
4. Cherian T. 2005. Describing the epidemiology and aetiology of bacterial pneumonia in children: an unresolved problem. Journal of Health, Population and Nutrition 23: 1-5.
5. Chocarro L, Duclos P, Senouci K, Southern J. 2011. Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups. Expert Review of Vaccines 10: 1265-70.
6. Druce N, Atim C, Grace C et al. 2006. Evidence-informed decision making processes for new vaccines and other technologies: strengthening capacity at country level. London: HLSP Ltd.
7. Duclos P, Okwo-Bele JM, Salisbury D. 2011. Establishing global policy recommendations: the role of the Strategic Advisory Group of Experts in immunization. Expert Review of Vaccines 10: 163-73.
8. Duclos P, Durrheim D, Reingold A et al. 2012. WHO's approach to developing evidence-based vaccine recommendations. Accepted manuscript.
9. Gordon W, Jones A, Wecker J. 2012. Introducing multiple vaccine in low- and lower-middle-income countries: issues, opportunities and challenges. Health Policy and Planning 27(Suppl. 2):ii17-ii26.
10. Jauregui B, Sinha A, Clark AD et al. 2011. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine 29: 1099-106.
11. Levine OS, Cherian T, Hajjeh R, Knoll MD. 2009. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clinical Infectious Diseases 48(Suppl. 2):S33-6.
12. Makinen M, Kaddar M, Molldrem V, Wilson L. 2012. New vaccine adoption in lower-middle-income countries. Health Policy and Planning 27(Suppl. 2):ii39-ii49.
13. McQuestion M, Gnawali D, Kamara C et al. 2011. Creating sustainable financing and support for immunization programs in fifteen developing countries. Health Affairs 30: 1134-40.
14. Milstein J, Dellepiane N, Belgharbi L, Chocarro L, Wood D. 2010. Assuring vaccine quality by strengthening regulatory agencies: the work of the World Health Organization. In: Levine MM (ed). New Generation Vaccines. New York: Informa Healthcare USA, Inc.
15. Nelson EAS, Gessner BD, DeRoeck D, Duclos P. 2010. The role of national advisory committees in supporting evidence-based decision making for national immunization programs. Vaccine 28(Suppl. 1).
16. O'Brien KL, Wolfson LJ, Watt JP et al. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet 374: 893-902.
17. Senouci K, Blau J, Nyambat B et al. 2010. The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative: a country-driven, multi-partner program to support evidence-based decision making. Vaccine 28(Suppl. 1):A26-30.
18. Watt JP, Wolfson LJ, O'Brien KL et al. 2009. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. The Lancet 374: 903-11.
19. Wonodi C, Privor-Dumm L, Levine O et al. 2012. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria. Health Policy and Planning 27(Suppl. 2):ii27-ii38.
20. WHO 1974. Resolution WHA 27.57. WHO Expanded Programme on Immunization. Twenty-seventh World Health Assembly, Geneva, 1974. WHA27/1974/REC/1. World Health Organization, Geneva.
21. WHO. 2005a. Vaccine introduction guidelines. Adding a vaccine to a national immunization programme: decision and implementation. WHO/IVB/05.18. Geneva: World Health Organization.
22. WHO. 2005. WHO-UNICEF guidelines for developing a comprehensive multi-year pan (cMYP). WHO/IVB/05.20. Geneva
23. WHO. 2006. Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies. WHO/IVB/05.19. Geneva: World Health Organization.
24. WHO. 2009. Global Action Plan for Prevention and Control of Pneumonia (GAPP). Geneva: World Health Organization / The United Nations Children's Fund.
25. WHO. 2010. New vaccine post-introduction evaluation (PIE) tool. WHO/ IVB/10.03. Geneva: World Health Organization.
26. WHO. 2011. Global Vaccine Safety Blueprint Project. Geneva: World Health Organization. Online at: http://www.who.int/immunization-safety/activities/GVS- blueprint-project/en/index.html, accessed 22 March 2012.